Latest news
Weekly Recap: Qtr revenue ~2.4% YoY and EMA CHMP backs Repatha - TradingViewTradingView · Mon, 03 Aug 2026 11:33:04 GMTHow Investors May Respond To Amgen (AMGN) Repatha Expansion and 2026 Dividend Declaration - simplywall.stsimplywall.st · Fri, 31 Jul 2026 03:38:35 GMTAmgen’s Repatha receives positive CHMP opinion for broader cardiovascular use - Pharmaceutical Business review -Pharmaceutical Business review - · Thu, 30 Jul 2026 14:31:43 GMTAmgen (AMGN) Wins Backing In Europe For Broader Repatha Use - finance.yahoo.comfinance.yahoo.com · Thu, 30 Jul 2026 07:00:00 GMTPOSITIVE CHMP OPINION SUPPORTS BROADER USE OF AMGEN'S REPATHA® BEFORE A FIRST HEART ATTACK OR STROKE - AmgenAmgen · Wed, 29 Jul 2026 07:00:00 GMT